A Framework for Crafting Clinical Practice Guidelines that are Relevant to the Care and Management of People with Multimorbidity
暂无分享,去创建一个
James Woodcock | Katrin Uhlig | Gordon Guyatt | Klara Brunnhuber | David Kent | Bruce Leff | Sheldon Greenfield | Louise C. Walter | Cynthia Mulrow | G. Guyatt | D. Kent | S. Greenfield | K. Schmader | B. Leff | C. Mulrow | K. Uhlig | L. Walter | C. Boyd | R. Leipzig | J. Woodcock | J. Burgers | H. Schunemann | S. Dy | Holger Schunemann | Cynthia M. Boyd | Rosanne Leipzig | K. High | Kevin High | Sydney Dy | Jako S. Burgers | Kenneth Schmader | K. Brunnhuber | Sydney Dy
[1] F. Hughes,et al. Quality of evidence , 2013, BDJ.
[2] Qian-Li Xue,et al. Difficulty Assisting with Health Care Tasks Among Caregivers of Multimorbid Older Adults , 2011, Journal of General Internal Medicine.
[3] K. Uhlig,et al. Guidelines for the older adult with CKD. , 2011, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[4] S. Kaplan,et al. Comorbidity Affects the Relationship Between Glycemic Control and Cardiovascular Outcomes in Diabetes , 2009, Annals of Internal Medicine.
[5] Gerald Gartlehner,et al. [GRADE guidelines: 8. Rating the quality of evidence - indirectness]. , 2012, Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen.
[6] Elvy Ickowicz. Guidelines for Improving the Care of the Older Person with Diabetes Mellitus , 2003 .
[7] G. Guyatt,et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations , 2008, BMJ : British Medical Journal.
[8] M. Puhan,et al. High prevalence of potential biases threatens the interpretation of trials in patients with chronic disease , 2011, BMC medicine.
[9] D. Singer,et al. Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. , 2012, Chest.
[10] P. Parfrey,et al. Preventing Nephropathy Induced by Contrast Medium , 2006 .
[11] A. Wu,et al. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. , 2005, JAMA.
[12] Gordon H Guyatt,et al. Credibility of claims of subgroup effects in randomised controlled trials: systematic review , 2012, BMJ : British Medical Journal.
[13] Diana B Petitti,et al. Update on the Methods of the U.S. Preventive Services Task Force: Insufficient Evidence , 2009, Annals of Internal Medicine.
[14] A. Macleod,et al. Clinical Practice Guideline for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease- Mineral and Bone Disorder (CKD-MBD) , 2009 .
[15] J. Kremer,et al. Feasibility of a Wiki as a Participatory Tool for Patients in Clinical Guideline Development , 2012, Journal of medical Internet research.
[16] G. Guyatt,et al. The Vexing Problem of Guidelines and Conflict of Interest: A Potential Solution , 2010, Annals of Internal Medicine.
[17] B. Thiers,et al. Eligibility Criteria of Randomized Controlled Trials Published in High-Impact General Medical Journals: A Systematic Sampling Review , 2008 .
[18] David M Kent,et al. Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal , 2010, Trials.
[19] Systematic review highlights difficulty interpreting diverse clinical outcomes in abnormal uterine bleeding trials. , 2011, Journal of clinical epidemiology.
[20] S. Wyke,et al. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study , 2012, The Lancet.
[21] David M Kent,et al. Limitations of applying summary results of clinical trials to individual patients: the need for risk stratification. , 2007, JAMA.
[22] Ravi Varadhan,et al. Multimorbidity and Evidence Generation , 2014, Journal of General Internal Medicine.
[23] K. Tashima,et al. Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[24] F. Légaré,et al. Patient and Public Involvement in Clinical Practice Guidelines , 2011, Medical decision making : an international journal of the Society for Medical Decision Making.
[25] Paul E. Johnson,et al. Values of Older Adults Related to Primary and Secondary Prevention , 2011 .
[26] Sandy S Chang,et al. Contribution of Multiple Chronic Conditions to Universal Health Outcomes , 2011, Journal of the American Geriatrics Society.
[27] Gordon H Guyatt,et al. GrADe : what is “ quality of evidence ” and why is it important to clinicians ? rATING quALITY of evIDeNCe AND STreNGTH of reCommeNDATIoNS , 2022 .
[28] J. Guralnik,et al. Patterns of functional decline at the end of life. , 2003, JAMA.
[29] B. Yawn,et al. How to integrate multiple comorbidities in guideline development: article 10 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report. , 2012, Proceedings of the American Thoracic Society.
[30] K. Covinsky,et al. Towards a combined prognostic index for survival in HIV infection: the role of ‘non‐HIV’ biomarkers , 2010, HIV medicine.
[31] M. Puhan,et al. Informing Evidence-Based Decision-Making for Patients with Comorbidity: Availability of Necessary Information in Clinical Trials for Chronic Diseases , 2012, PloS one.
[32] M. Tinetti,et al. Potential pitfalls of disease-specific guidelines for patients with multiple conditions. , 2004, The New England journal of medicine.
[33] Michael K Gould,et al. An official ATS statement: grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations. , 2006, American journal of respiratory and critical care medicine.
[34] P. Parfrey,et al. Clinical practice. Preventing nephropathy induced by contrast medium. , 2006, The New England journal of medicine.
[35] G. Guyatt,et al. Comparing the USPSTF and GRADE Approaches to Recommendations , 2009, Annals of Internal Medicine.
[36] Therese Miller,et al. How to Read the New Recommendation Statement: Methods Update from the U.S. Preventive Services Task Force , 2007, Annals of Internal Medicine.
[37] Kdoqi. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease. , 2007, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[38] Douglas K Owens,et al. Grading the Strength of a Body of Evidence When Comparing Medical Interventions , 2009 .
[39] G. Guyatt,et al. Patient values and preferences in decision making for antithrombotic therapy: a systematic review: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. , 2012, Chest.
[40] T. Trikalinos,et al. Addressing Multimorbidity in Evidence Integration and Synthesis , 2014, Journal of General Internal Medicine.
[41] Mark S Roberts,et al. A framework for tailoring clinical guidelines to comorbidity at the point of care. , 2007, Archives of internal medicine.
[42] Douglas K Owens,et al. AHRQ series paper 5: grading the strength of a body of evidence when comparing medical interventions--agency for healthcare research and quality and the effective health-care program. , 2010, Journal of clinical epidemiology.
[43] Tracy A Wolff,et al. Reconsidering the Approach to Prevention Recommendations for Older Adults , 2010, Annals of Internal Medicine.
[44] Ameen Abu-Hanna,et al. Characterizing Predictive Models of Mortality for Older Adults and Their Validation for Use in Clinical Practice , 2011, Journal of the American Geriatrics Society.
[45] Cathy Schoen,et al. Toward higher-performance health systems: adults' health care experiences in seven countries, 2007. , 2007, Health affairs.
[46] A. Ucci,et al. Rapidly progressive glomerulonephritis after immunotherapy for cancer. , 1995, Journal of the American Society of Nephrology : JASN.
[47] S. Galea,et al. Sexual Violence and Mental Health Symptoms Among National Guard and Reserve Soldiers , 2013, Journal of General Internal Medicine.
[48] Gordon H Guyatt,et al. Executive Summary Antithrombotic Therapy and Prevention of Thrombosis , 9 th ed : American College of Chest Physicians Evidence-Based Clinical Practice Guidelines , 2012 .
[49] Paolo Prandoni,et al. Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. , 2012, Chest.
[50] David M. Kent,et al. Evidence-Based Medicine and the Hard Problem of Multimorbidity , 2014, Journal of general internal medicine.
[51] William F. Lawrence,et al. Chapter 10: Deciding Whether to Complement a Systematic Review of Medical Tests with Decision Modeling , 2012, Journal of General Internal Medicine.
[52] Gert P. Westert,et al. Current Guidelines Have Limited Applicability to Patients with Comorbid Conditions: A Systematic Analysis of Evidence-Based Guidelines , 2011, PloS one.
[53] Donna M. Zulman,et al. Examining the Evidence: A Systematic Review of the Inclusion and Analysis of Older Adults in Randomized Controlled Trials , 2011, Journal of General Internal Medicine.
[54] Mara A Schonberg,et al. Prognostic indices for older adults: a systematic review. , 2012, JAMA.
[55] Nathaniel Clark,et al. Diabetes in Older Adults , 2012, Diabetes Care.
[56] Amy C. Justice,et al. The Payoff Time: A Flexible Framework to Help Clinicians Decide When Patients With Comorbid Disease are not Likely to Benefit From Practice Guidelines , 2009, Medical care.
[57] F. Pouwer,et al. Type 2 diabetes mellitus as a risk factor for the onset of depression: a systematic review and meta-analysis , 2010, Diabetologia.